Pacific Biosciences of California PACB Change in Lease Liabilities
Change in Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's change in lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's change in lease liabilities?
- Pacific Biosciences of California (PACB) reported change in lease liabilities of $1.43M in Q1 2026.
- How has Pacific Biosciences of California's change in lease liabilities changed year-over-year?
- Pacific Biosciences of California's change in lease liabilities increased by 188.1% year-over-year, from -$1.62M to $1.43M.
- What is the long-term trend for Pacific Biosciences of California's change in lease liabilities?
- Over 3 years (2022 to 2025), Pacific Biosciences of California's change in lease liabilities has grown at a -54.6% compound annual growth rate (CAGR), from -$7.72M to $723K.
- What does change in lease liabilities mean?
- Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.